highly significantp < 0.001
The frequency of APOE ε4 carrier status was 68.9% in the AD group, 38.2% in the MCI group, and 17.8% in the HC group, with highly significant differences detected across groups ( p < 0.001).
The frequency of APOE ε4 carrier status was 68.9% in the AD group, 38.2% in the MCI group, and 17.8% in the HC group, with highly significant differences detected across groups ( p < 0.001).